0001437749-22-013128.txt : 20220519
0001437749-22-013128.hdr.sgml : 20220519
20220519203910
ACCESSION NUMBER: 0001437749-22-013128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220517
FILED AS OF DATE: 20220519
DATE AS OF CHANGE: 20220519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hahne Vicky
CENTRAL INDEX KEY: 0001716043
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 22945002
MAIL ADDRESS:
STREET 1: C/O CELCUITY, 16305 36TH AVENUE N.
STREET 2: #450
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-05-17
0001603454
Celcuity Inc.
CELC
0001716043
Hahne Vicky
16305 36TH AVENUE N.
SUITE 100
MINNEAPOLIS
MN
55446
1
Chief Financial Officer
Common Stock
12903
D
Stock Option (right to buy)
8.4000
2027-05-17
Common Stock
37500
37500
D
Stock Option (right to buy)
23.48
2022-05-17
4
D
0
3000
D
2028-07-05
Common Stock
3000
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
3000
A
2028-07-05
Common Stock
3000
3000
D
Stock Option (right to buy)
25.77
2022-05-17
4
D
0
932
D
2028-10-17
Common Stock
932
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
932
A
2028-10-17
Common Stock
932
932
D
Stock Option (right to buy)
19.72
2022-05-17
4
D
0
3000
D
2029-08-12
Common Stock
3000
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
3000
A
2029-08-12
Common Stock
3000
3000
D
Stock Option (right to buy)
5.9000
2030-08-12
Common Stock
10000
10000
D
Stock Option (right to buy)
10.35
2022-05-17
4
D
0
1122
D
2030-12-28
Common Stock
1122
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
1122
A
2030-12-28
Common Stock
1122
1122
D
Stock Option (right to buy)
14.84
2022-05-17
4
D
0
1301
D
2031-02-02
Common Stock
1301
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
1301
A
2031-02-02
Common Stock
1301
1301
D
Stock Option (right to buy)
15.92
2022-05-17
4
D
0
1204
D
2031-03-18
Common Stock
1204
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
1204
A
2031-03-18
Common Stock
1204
1204
D
Stock Option (right to buy)
27.94
2022-05-17
4
D
0
3806
D
2031-04-12
Common Stock
3806
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
3806
A
2031-04-12
Common Stock
3806
3806
D
Stock Option (right to buy)
20.04
2022-05-17
4
D
0
15000
D
2031-08-11
Common Stock
15000
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
15000
A
2031-08-11
Common Stock
15000
15000
D
Stock Option (right to buy)
17.19
2022-05-17
4
D
0
821
D
2031-10-27
Common Stock
821
0
D
Stock Option (right to buy)
5.50
2022-05-17
4
A
0
821
A
2031-10-27
Common Stock
821
821
D
Stock Option (Right to Buy)
5.50
2022-05-17
4
A
0
31930
0
A
2032-05-17
Common Stock
31930
31930
D
Includes 1,972 shares acquired on October 29, 2021 and 2,000 shares acquired on April 30, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.
Fully vested.
750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter.
233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter.
750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter.
2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter.
280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter.
325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter.
301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter.
952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter.
3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter.
205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter.
These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022.
The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
/s/ Eric O. Madson as Attorney-in-Fact for Vicky Hahne pursuant to Power of Attorney previously filed.
2022-05-19